Evidence map›Paper›PMID 41752431›Full record

ArticleMolecules (Basel, Switzerland)2026

Biodistribution of Tc-99m-Labeled Solid Lipid Nanoparticles and Evaluation of Their Possibility as a Radiopharmaceutical.

Hayrettin Eroglu, Arif Kürsad Ayan, Ayse Yenilmez

Erratum issuedAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Hayrettin ErogluDepartment of Chemical Engineering, Faculty of Engineering and Architecture, Erzurum Technical University, 25110 Erzurum, Türkiye.ORCID 0000-0001-8197-4162
Arif Kürsad AyanDepartment of Nuclear Medicine, Samsun Medicana Hospital, 55100 Samsun, Türkiye.
Ayse YenilmezDepartment of Mathematics and Science Education, Faculty of Education, Van Yüzüncü Yıl University, 65080 Van, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid lipid nanoparticles (SLNs) are submicron colloidal systems widely investigated as drug carriers; however, their intrinsic biodistribution properties are also critical when SLNs are considered for diagnostic imaging. In the present proof-of-concept study, drug-free SLNs were evaluated exclusively as a radiolabeled imaging agent rather than as a drug delivery system. SLNs were radiolabeled with Technetium-99m (

Indexed as

LipidsNanoparticlesRadiopharmaceuticalsTechnetiumAnimalsLiposomesLiverRabbitsRadionuclide ImagingSpleenTissue DistributionLipid NanoparticlesLipidsLiposomesRadiopharmaceuticalsTechnetiumbiodistributiondrug deliveryscintigraphysolid lipid nanoparticleTc-99m

Identifiers

PMID41752431
PMCPMC12943629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.